SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Targacept (TRGT)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (5)9/28/2006 11:34:01 AM
From: keokalani'nuiRead Replies (2) of 40
 
The overhang is due to AZN's re-do of some prelinincal and P1 work and if they don't like what they see trgt has to pay for the work. Drop dead date is 4-23-07.

--repeat dog CV study
--full p1 work up with liver metabolism (450 cytochrome questions), CV
--ddi especially with anti-psychotics

Company shrugs it all off. Makes me wonder what I'm doing here? No guts....no
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext